Search clinical trials for: VISIPAQUE 270

Total 5142 results

Bracco Diagnostics, Inc

Completed

Isovue in Peripheral Digital Subtraction Angiography (DSA)

Peripheral Arterial Occlusive Disease

United States
Bracco Diagnostics, Inc

Completed

Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA

Peripheral Arterial Occlusive Disease
Norwegian University of Science and Technology

Completed

DynaCT in Preoperative Imaging Before Insertion of Stentgraft (DynaCT)

Abdominal Aortic Aneurysm

Norway
Medical University of South Carolina
General Electric

Completed

Aortic Stenosis Pre-Transcatheter Aortic Valve Replacement (TAVR) Procedure CT Scan

Aortic Valve Stenosis

United States
Bracco Diagnostics, Inc

Completed

Kidney Damage in Patients With Moderate Fall in eGFR

Coronary Artery Stenosis

Canada, United States
Bracco Diagnostics, Inc

Completed

Kidney Damage in Patients With Normal eGFR

Coronary Artery Stenosis

United States
Chinese PLA General Hospital

Completed

A Safety Comparison of Iopromide and Iodixanol in Renal Impaired Patients (DIRECT)

Kidney Failure, Chronic

China
Duke University

Completed

Comparison of Isovue 370 vs. Standard Protocol in Coronary Computed Tomographic Angiography (CTA)

Coronary Computed Tomographic Angiography
GE Healthcare
i3 Statprobe

Completed

Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis

Patient Comfort and Safety

United States
GE Healthcare
Syneos Health

Terminated

A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney Disease

Chronic Kidney Diseases

United States, Spain, Belgium, Canada, Poland, United Kingdom
GE Healthcare

Completed

Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEMI) Participants Undergoing Primary Percutaneous Coronary Intervention (PCI) Procedure With VISIPAQUE® as the Contrast Medium

Coronary Artery Disease | ST-segment Elevation Myocardial Infarction

China, Korea, Republic of
Minneapolis Heart Institute Foundation

Recruiting

Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography (GE OCT)

Coronary Artery Disease | Contrast Media Reaction

United States
GE Healthcare
i3 Statprobe

Completed

Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography

Drug Safety

United States
GE Healthcare

Terminated

Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart

Coronary Artery Disease

United States
GE Healthcare

Terminated

Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart

Coronary Artery Disease

United States
Ospedale San Donato
Ospedale Le Scotte; Ospedale della Misericordia - Grosseto

Completed

Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI) (CONTRAST-AMI)

Acute Myocardial Infarction | Contrast Induced Nephropathy

Italy
GE Healthcare
Medpace, Inc.; i3 Statprobe

Completed

Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT)

Healthy

United States
MedImmune LLC
Amgen

Completed

Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma

Asthma

United States, Slovakia, Israel, South Africa, Ukraine, Japan, Czechia, Hungary, Bulgaria, Serbia, Latvia, Lithuania
Deutsches Herzzentrum Muenchen

Completed

Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)

Renal Insufficiency, Chronic | Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary

Germany
Stanford University

Terminated

Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection

Pancreatic Cancer

United States
Guerbet

Terminated

Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography (CINOPSIS CT)

Renal Impairment

United States
GE Healthcare
Quintiles, Inc.; Covance; ABX CRO; Examination Management Services Inc.; Averion...

Terminated

Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography

Diabetes Mellitus | Renal Insufficiency

United States, United Kingdom
Guerbet

Completed

A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications

Diagnostic Imaging

France
Enrico Ammirati

Completed

IMaging Della PLAcca Carotidea (IMPLAC)

Ischemic Stroke | Atherosclerosis | Carotid Artery Plaque
VA Greater Los Angeles Healthcare System

Withdrawn

Efficacy of Low (30ml) Versus Full Dose (100ml) Contrast CT Pulmonary Angiography in Detecting Emboli

Multiple Pulmonary Emboli

United States
Chinese PLA General Hospital

Completed

Central Venous Pressure Guided Hydration Prevention for Contrast-Induced Nephropathy

Cardio-Renal Syndrome

China
AO Clinical Investigation and Publishing Documentation

Completed

Proximal Femoral Nail Antirotation (PFNA) Versus PFNA Augmentation

Hip Fractures | Closed Fracture of Hip

Israel, Austria, Switzerland, Germany, Belgium, Norway
Maastricht University Medical Center
Bayer

Completed

Contrast Enhancement on Coronary Computed Tomographic Angiography (EICAR)

Coronary Artery Disease | Coronary Stenosis

Netherlands
AxeroVision, Inc.

Completed

Evaluation of AXR-270 for the Treatment of Posterior Blepharitis Associated With Meibomian Gland Dysfunction

Meibomian Gland Dysfunction | Posterior Blepharitis

United States
Bracco Diagnostics, Inc

Completed

Coronary MDCTA With Iopamidol Injection 370

Coronary Artery Disease

United States
GE Healthcare
Bayer; Guerbet/Liebel-Flarsheim

Withdrawn

Pediatric Risk of Hypothyroidism With Iodinated Contrast Media

Hypothyroidism
Mayo Clinic

Recruiting

Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption

Brain Tumor

United States
University of Reading

Completed

Effects of A2 Milk on Gastrointestinal Function in Non-lactose Milk Intolerance

Milk Intolerance

United Kingdom
Yuhan Corporation

Active, not recruiting

Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)

Non-Small Cell Lung Cancer

Hungary, Korea, Republic of, Australia, Taiwan, Serbia, Singapore, Thailand, Philippines, Turkey, Malaysia, Russian Federation, Greece, Ukraine
Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company

Withdrawn

Safety and Tolerability Study of VTS-270 in Pediatric Participants With Niemann-Pick Type C (NPC) Disease

Niemann-Pick Disease, Type C
Mandos LLC

Terminated

Niemann-Pick Type C Treatment With Adrabetadex for Symptoms of Brain and Nervous System

Niemann-Pick Type C Disease

United States
Bausch Health Americas, Inc.

Completed

Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis

Psoriasis
Drugs for Neglected Diseases

Completed

ADME Study of Acoziborole in Healthy Subjects

Trypanosomiases, African

United Kingdom
OPKO Health, Inc.

Withdrawn

Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018) (2007)

Secondary Hyperparathyroidism (SHPT) | Stage 5 Chronic Kidney Disease (CKD) | Hemodialysis (HD)
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects

Dyslipidemias

Korea, Republic of
Boryung Pharmaceutical Co., Ltd
Covance

Completed

Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects

Essential Hypertension
NYU Langone Health
Guerbet

Completed

Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography

Coronary Artery Disease

United States
Jena University Hospital
German Research Foundation; Instituto Grifols, S.A.; University Hospital Goettingen and other collaborators

Recruiting

Albumin Replacement Therapy in Septic Shock (ARISS)

Septic Shock

Germany
Shaheed Zulfiqar Ali Bhutto Medical University

Completed

Tocilizumab and Cytokine Release Syndrome (CRS) In Covid-19 Pneumonia

Cytokine Release Syndrome | Covid-19 Pneumonia

Pakistan
National Cancer Institute (NCI)

Completed

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Brain Stem Neoplasm | Pineal Region Neoplasm | Recurrent Visual Pathway Glioma | Refractory Visual Pathway Glioma

United States
aTyr Pharma, Inc.

Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Interstitial Lung Disease

United States
Eunice Kennedy Shriver National Institute of Child...

Terminated

Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease, Type C1

Niemann-Pick Disease, Type C1

United States
Impax Laboratories, LLC

Completed

Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease

Idiopathic Parkinson's Disease

United States
Hamamatsu University

Completed

Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication

Gastritis Associated With Helicobacter Pylori

Japan
National Cancer Institute (NCI)

Withdrawn

Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumors and Lymphomas

Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Pancreatic Carcinoma | Refractory T-Cell Non-Hodgkin Lymphoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC... and other conditions

Search clinical trials for: VISIPAQUE 270

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations